This ENZ PE ratio history page last updated 1/30/2025

Period | Price | Adj. EPS | TTM | PE |
Q1 2025 12/16/2024 | 1.01 | -0.05 | -0.10 | NA | Q4 2024 10/29/2024 | 1.13 | -0.01 | -0.05 | NA | Q3 2024 6/13/2024 | 1.13 | -0.04 | -0.35 | NA | Q2 2024 3/13/2024 | 1.23 | 0.00 | -0.31 | NA | Q3 2023 6/14/2023 | 1.93 | -0.31 | -0.72 | NA | Q2 2023 3/21/2023 | 2.04 | -0.23 | -0.67 | NA | Q1 2023 12/12/2022 | 1.85 | -0.18 | -0.41 | NA | Q4 2022 10/14/2022 | 2.12 | -0.17 | -0.27 | NA | Q3 2022 6/9/2022 | 2.24 | -0.09 | -0.03 | NA | Q2 2022 3/14/2022 | 3.01 | 0.03 | 0.10 | 30.1 | Q1 2022 12/15/2021 | 3.48 | -0.04 | 0.16 | 21.8 | Q4 2021 10/12/2021 | 3.81 | 0.07 | 0.21 | 18.1 | Q3 2021 6/9/2021 | 3.20 | 0.04 | 0.07 | 45.7 | Q2 2021 3/15/2021 | 2.96 | 0.09 | -0.14 | NA | Q1 2021 12/9/2020 | 2.49 | 0.01 | -0.35 | NA | Q4 2020 10/13/2020 | 2.61 | -0.07 | -0.49 | NA | Q3 2020 6/8/2020 | 2.74 | -0.17 | -0.53 | NA | Q2 2020 3/5/2020 | 2.26 | -0.12 | -0.50 | NA | Q1 2020 12/10/2019 | 2.85 | -0.13 | -0.56 | NA | Q4 2019 10/15/2019 | 3.37 | -0.11 | -0.56 | NA | Q3 2019 6/10/2019 | 3.52 | -0.14 | -0.57 | NA | Q2 2019 3/11/2019 | 3.09 | -0.18 | -0.49 | NA | Q1 2019 12/10/2018 | 3.27 | -0.13 | -0.35 | NA | Q4 2018 10/15/2018 | 4.13 | -0.12 | -0.23 | NA | Q3 2018 6/11/2018 | 6.70 | -0.06 | -0.15 | NA | Q2 2018 3/13/2018 | 6.70 | -0.04 | -0.09 | NA | Q1 2018 12/7/2017 | 9.51 | -0.01 | -0.07 | NA | Q4 2017 9/27/2017 | 11.44 | -0.04 | -0.09 | NA | Q3 2017 6/8/2017 | 9.16 | 0.00 | -0.09 | NA | Q2 2017 3/13/2017 | 6.92 | -0.02 | -0.13 | NA | Q1 2017 12/8/2016 | 7.48 | -0.03 | -0.18 | NA | Q4 2016 10/13/2016 | 5.07 | -0.04 | -0.20 | NA | Q3 2016 6/8/2016 | 6.23 | -0.04 | -0.22 | NA | Q2 2016 3/9/2016 | 4.31 | -0.07 | -0.25 | NA | Q1 2016 12/7/2015 | 4.51 | -0.05 | -0.27 | NA | Q4 2015 10/13/2015 | 3.79 | -0.06 | -0.30 | NA | Q3 2015 6/9/2015 | 3.10 | -0.07 | -0.30 | NA | Q2 2015 3/12/2015 | 3.08 | -0.09 | -0.28 | NA | Q1 2015 12/9/2014 | 4.88 | -0.08 | -0.28 | NA | Q4 2014 10/9/2014 | 4.77 | -0.06 | -0.27 | NA | Q3 2014 6/9/2014 | 4.59 | -0.05 | -0.29 | NA | Q2 2014 3/11/2014 | 3.84 | -0.09 | -0.39 | NA | Q1 2014 12/10/2013 | 2.45 | -0.07 | -0.44 | NA | Q4 2013 10/15/2013 | 2.42 | -0.08 | -0.46 | NA | Q3 2013 6/10/2013 | 2.27 | -0.15 | -0.47 | NA | Q2 2013 3/12/2013 | 2.87 | -0.14 | NA | NA | Q3 2012 12/10/2012 | 2.69 | -0.09 | NA | NA | Q1 2013 10/15/2012 | 1.98 | -0.09 | NA | NA |
|

Period | Price | Adj. EPS | Annualized | PE |
Q1 2025 12/16/2024 | 1.01 | -0.05 | -0.20 | NA | Q4 2024 10/29/2024 | 1.13 | -0.01 | -0.04 | NA | Q3 2024 6/13/2024 | 1.13 | -0.04 | -0.16 | NA | Q2 2024 3/13/2024 | 1.23 | 0.00 | 0.00 | NA | Q3 2023 6/14/2023 | 1.93 | -0.31 | -1.24 | NA | Q2 2023 3/21/2023 | 2.04 | -0.23 | -0.92 | NA | Q1 2023 12/12/2022 | 1.85 | -0.18 | -0.72 | NA | Q4 2022 10/14/2022 | 2.12 | -0.17 | -0.68 | NA | Q3 2022 6/9/2022 | 2.24 | -0.09 | -0.36 | NA | Q2 2022 3/14/2022 | 3.01 | 0.03 | 0.12 | 25.1 | Q1 2022 12/15/2021 | 3.48 | -0.04 | -0.16 | NA | Q4 2021 10/12/2021 | 3.81 | 0.07 | 0.28 | 13.6 | Q3 2021 6/9/2021 | 3.20 | 0.04 | 0.16 | 20.0 | Q2 2021 3/15/2021 | 2.96 | 0.09 | 0.36 | 8.2 | Q1 2021 12/9/2020 | 2.49 | 0.01 | 0.04 | 62.3 | Q4 2020 10/13/2020 | 2.61 | -0.07 | -0.28 | NA | Q3 2020 6/8/2020 | 2.74 | -0.17 | -0.68 | NA | Q2 2020 3/5/2020 | 2.26 | -0.12 | -0.48 | NA | Q1 2020 12/10/2019 | 2.85 | -0.13 | -0.52 | NA | Q4 2019 10/15/2019 | 3.37 | -0.11 | -0.44 | NA | Q3 2019 6/10/2019 | 3.52 | -0.14 | -0.56 | NA | Q2 2019 3/11/2019 | 3.09 | -0.18 | -0.72 | NA | Q1 2019 12/10/2018 | 3.27 | -0.13 | -0.52 | NA | Q4 2018 10/15/2018 | 4.13 | -0.12 | -0.48 | NA | Q3 2018 6/11/2018 | 6.70 | -0.06 | -0.24 | NA | Q2 2018 3/13/2018 | 6.70 | -0.04 | -0.16 | NA | Q1 2018 12/7/2017 | 9.51 | -0.01 | -0.04 | NA | Q4 2017 9/27/2017 | 11.44 | -0.04 | -0.16 | NA | Q3 2017 6/8/2017 | 9.16 | 0.00 | 0.00 | NA | Q2 2017 3/13/2017 | 6.92 | -0.02 | -0.08 | NA | Q1 2017 12/8/2016 | 7.48 | -0.03 | -0.12 | NA | Q4 2016 10/13/2016 | 5.07 | -0.04 | -0.16 | NA | Q3 2016 6/8/2016 | 6.23 | -0.04 | -0.16 | NA | Q2 2016 3/9/2016 | 4.31 | -0.07 | -0.28 | NA | Q1 2016 12/7/2015 | 4.51 | -0.05 | -0.20 | NA | Q4 2015 10/13/2015 | 3.79 | -0.06 | -0.24 | NA | Q3 2015 6/9/2015 | 3.10 | -0.07 | -0.28 | NA | Q2 2015 3/12/2015 | 3.08 | -0.09 | -0.36 | NA | Q1 2015 12/9/2014 | 4.88 | -0.08 | -0.32 | NA | Q4 2014 10/9/2014 | 4.77 | -0.06 | -0.24 | NA | Q3 2014 6/9/2014 | 4.59 | -0.05 | -0.20 | NA | Q2 2014 3/11/2014 | 3.84 | -0.09 | -0.36 | NA | Q1 2014 12/10/2013 | 2.45 | -0.07 | -0.28 | NA | Q4 2013 10/15/2013 | 2.42 | -0.08 | -0.32 | NA | Q3 2013 6/10/2013 | 2.27 | -0.15 | -0.60 | NA | Q2 2013 3/12/2013 | 2.87 | -0.14 | -0.56 | NA | Q3 2012 12/10/2012 | 2.69 | -0.09 | -0.36 | NA | Q1 2013 10/15/2012 | 1.98 | -0.09 | -0.36 | NA |
|
On this page we presented the ENZ PE Ratio History information for Enzo Biochem' stock.
The average ENZ PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 25.8. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average ENZ PE ratio history based on this TTM earnings result method is 28.9. Note: any PE calculations involving negative earnings were discarded as not meaningful.
Let's now compare this ENZ PE ratio history result, against the recent PE: when this page was posted on 1/29/2025, the most recent closing price for ENZ had been 0.63, and the most recent quarterly earnings result, annualized, was 0.12. Meanwhile, the most recent TTM earnings summed to 0.1. From these numbers, we calculate the recent ENZ PE on 1/29/2025 based on annualized quarterly EPS was 5.2. Based on ENZ's history, that recent PE is low relative to the historical average, with the recent PE 79.8% lower than the historical average PE across our data set for Enzo Biochem. Looking at the recent ENZ PE on 1/29/2025 based on TTM EPS, we calculate the ratio at 6.3. Based on ENZ's history, that recent PE is low relative to the historical average, with the recent PE 78.2% lower than the average PE across our Enzo Biochem data set with TTM EPS used in the calculation at each period.
For self directed investors doing their due diligence on ENZ or any other given stock, valuation analysis for ENZ
can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can
help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios
justify the current stock market value.
That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate
Enzo Biochem PE ratio history — or the PE history for any stock in our coverage universe.
And in your continued research we hope you will be sure to check out the further links included for
next earnings dates and also historical earnings surprises history for ENZ. Thanks for visiting, and the next
time you need to research ENZ PE Ratio History or the PE ratio history for another stock, we hope our site
will come to mind as your go-to PE ratio history research resource of choice.